COR Q3 2023 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q3 2023 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$66.9B+11.5% YoY

Gross Profit

$1.9B2.8% margin

Operating Income

$568M0.8% margin

Net Income

$480M0.7% margin

EPS (Diluted)

$2.35

QoQ Revenue Growth

+5.5%

Cash Flow

Operating Cash Flow

$745M

Free Cash Flow

$641M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$61.2B

Total Liabilities

$60.3B

Stockholders' Equity

$686M

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66.9B	$60.1B	+11.5%
Gross Profit	$1.9B	$1.8B	+1.5%
Operating Income	$568M	$631M	-10.1%
Net Income	$480M	$407M	+17.8%

Revenue Segments

Pharmaceutical Distribution

$58.6B88%

International Healthcare Solutions

$7.0B11%

Animal Health

$1.3B2%

Geographic Segments

U.S. Healthcare Solutions

$59.9B89%

International Healthcare Solutions

$7.0B11%